Study Finds 94% of Nursing Students Support Legalizing Medical Marijuana

A significant majority of nursing students believe that patients should have legal access to medical marijuana, yet many report a lack of adequate training on the subject during their education, according to a recent survey published in the journal Nurse Practitioner.

Researchers from Simmons College in Boston conducted a survey of over 100 nurse practitioner (NP) students. Researchers found that most students (94%) felt that medical marijuana (MM) should be legalized in all US states. Likewise, 97% felt that MM education should be included in NP program curricula.

However, researchers found that “only 30% reported receiving in-depth education on the topic.”
Continue reading

Federally Funded Study: Marijuana and Psychedelics Use at Historic Highs, Cigarette Use at Historic Low

The past-year use of cannabis and psychedelics (referred to in the study as hallucinogens) stayed at historically high levels in 2023 among adults aged 19 to 30 and 35 to 50, according to the latest findings from the Monitoring the Future survey.

In contrast, past-year use of cigarettes remained at historically low levels in both adult groups. Past-month and daily alcohol use continued a decade-long decline among those 19 to 30 years old, with binge drinking reaching all-time lows. However, among 35- to 50-year-olds, the prevalence of binge drinking in 2023 increased from five and 10 years ago.

The Monitoring the Future study, which has been issued annually since 1975, is conducted by scientists at the University of Michigan’s Institute for Social Research, Ann Arbor, and is funded by the National Institutes of Health.
Continue reading

Study: Cannabinoids Associated With Improved Quality of Life in Both Chron’s Disease and Ulcerative Colitis

According to a new meta-analysis of clinical trials, “cannabinoids are associated with improved quality of life in both CD and UC, as well as improved disease activity”.

Titled Meta-analysis of the Therapeutic Impact of Cannabinoids in Inflammatory Bowel Disease, the study was published in the journal Inflammatory Bowel Diseases, issued by Oxford University, and it was conducted by researchers from the University of Pennsylvania.

“With the increasing legalization of medical and recreational cannabis, patients and providers have growing interest in the role of cannabinoids in treating inflammatory bowel disease”, states the study’s abstract. “Prior meta-analysis has shown inconclusive evidence for efficacy of cannabinoids.” With that in mind, researchers “sought to produce an up-to-date meta-analysis that pools new data to evaluate the therapeutic effects of cannabinoids in both Crohn’s disease (CD) and ulcerative colitis (UC).”
Continue reading

California Legislature Passes Bill to Legalize Marijuana Cafés, Sending it to Governor Newsom

California’s full legislature has passed legislation to legalize marijuana cafés, officially sending the bill to Governor Gavin Newsom.

Yesterday the Assembly concurred with changes that the Senate made to Assembly Bill 1775 prior to its passage. Both chambers have now passed the same version of the bill, allowing it to be sent to Governor Newsom.

The final vote in the Assembly was 58 to 6, with the final vote in the Senate being 30 to 7.
Continue reading

Psilocybin Therapy for Chronic Lower Back Pain: University of California Seeks Participants for Clinical Trial

The University of California (UC) is seeking participants for a double-blind, randomized clinical trial “examining the preliminary efficacy of psilocybin therapy for people with chronic low back pain”.

(Photo credit: TheScientist).

“This study evaluates whether psilocybin therapy helps patients cope with chronic low back pain more effectively”, states a public posting .” Patients may be recruited at Stanford and University of California San Francisco (UCSF), study procedures will occur at UCSF.”

Each participant “will receive a dose of psilocybin with possibly one or more other drugs. Participants will undergo two preparation sessions, a dosing session, three integration sessions to discuss their psilocybin experience, and several follow up sessions.”
Continue reading

California Senate Gives Final Approval to Legislation Allowing Marijuana Growers to Sell at Farmers Markets

Legislation that would allow certain licensed marijuana growers in California to sell directly to consumers at farmers markets has been passed through its third and final reading in the Senate.

Last week we reported that Assembly Bill 1111 was passed through its second reading in the full Senate and was ordered to a third and final reading. Now, the measure has been passed by the Senate through its third reading by a vote of 27 to 5.

Sponsored by Assemblymember Gail Pellerin (D), AB 1111 authorizes the Department of Cannabis Control (DCC) to issue temporary event licenses, enabling on-site cannabis sales and consumption at approved venues within jurisdictions that explicitly allow such activities. The bill also includes specific criteria for small marijuana producers eligible for these licenses, limiting cultivation to no more than one acre or specific square footage under different types of licenses.
Continue reading

Canada: Over $2.4 Billion in Legal Marijuana Sold in First Half of 2024

According to data compiled and released by Statistics Canada, there was over $2.4 billion worth of marijuana and marijuana products sold legally in the first half of 2024.

Between January and June of this year, licensed marijuana stores sold $2.425 billion in legal marijuana, putting the nation on track for nearly $5 billion for the year.

During this period, May saw the highest amount of marijuana sales with $413.6 million. February experienced the lowest sales with $386.8 million.
Continue reading

Yale School of Medicine Paying $495 to Participate in Stress-Related Marijuana Study

The Yale School of Medicine is seeking those 18 and older for a paid marijuana study.

The Yale Stress Center at the Yale School of Medicine “is looking for individuals who are at least 18 years old and smoke marijuana at least once per week to participate in a research study.” Participants will receive compensation up to $495.

At the Yale Stress Center, researchers “develop, test and validate both behavioral and pharmacological interventions strategies to reduce the toxic effects of trauma and stress and help promote resilience.” These include “mindfulness, stress reduction, nutrition, and physical activity counseling to enhance your health and the health of your family.”
Continue reading

Six Months Ago, Vice President Harris Said She and Biden “Changed Federal Marijuana Policy”: It Still Hasn’t Happened

In a campaign video posted on the social media platform X on February 9, Vice President Kamala Harris stated that the Biden/Harris Administration has “changed federal marijuana policy”.

A screenshot from the X.com video post by VP Harris in February.

In the video, which now has been viewed nearly 450,000 times and shared over 2,000 times, VP Harris said “We changed federal marijuana policy, because nobody should have to go to jail just for smoking weed.”

At the time, it was thought that Harris’ video was simply posted prematurely: The Biden Administration had not made any changes to federal marijuana policy, but the DEA was considering a move to reschedule the plant to Schedule III. The Harris campaign declined to respond to media inquiries about what the VP meant by her remarks.
Continue reading

U.S. Appeals Court Rules Former Marijuana Users Can Legally Own Guns, Citing Unconstitutional Federal Ban

In a major decision, a U.S. appeals court has ruled that a Texas resident cannot be prosecuted under a federal law that prohibits drug users from owning firearms, stating that the law is unconstitutional when applied to individuals with past drug use.

This ruling follows a recent Supreme Court decision that broadened the interpretation of the Second Amendment.

The 5th U.S. Circuit Court of Appeals determined that the federal ban on firearm ownership for drug users should not apply to Texas resident Paola Connelly, as it unjustly targets individuals based on their previous drug habits.
Continue reading